We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

39 hedge funds and large institutions have $13.7M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,075% more call options, than puts

Call options by funds: $367K | Put options by funds: $4K

17% less funds holding

Funds holding: 47 → 39 (-8)

49% less capital invested

Capital invested by funds: $26.9M → $13.7M (-$13.1M)

72% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 18

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
39
Holders Change
-8
Holders Change %
-17.02%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
18
Closed
9
Calls
$367K
Puts
$4K
Net Calls
+$363K
Net Calls Change
-$604K

Top Buyers

Rank Fund Capital Flow
1
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$192K
2
BCM
Bridgeway Capital Management
Texas
+$68.5K
3
Citigroup
Citigroup
New York
+$19.9K
4
VF
Virtu Financial
New York
+$3.48K
5
US Bancorp
US Bancorp
Minnesota
+$3.42K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$337K
2
Citadel Advisors
Citadel Advisors
Florida
-$210K
3
Belvedere Trading
Belvedere Trading
Illinois
-$207K
4
Two Sigma Investments
Two Sigma Investments
New York
-$174K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$170K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$4.01M – – –
NHAS
2
Novo Holdings A/S
Denmark
$3.2M – – –
Blackstone Inc
3
Blackstone Inc
New York
$2.18M – – –
TCM
4
Tekla Capital Management
Massachusetts
$1.17M – – –
NFGH
5
Nan Fung Group Holdings
Hong Kong
$797K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$567K -$2.41K -1,409 -0.3%
BlackRock
7
BlackRock
New York
$410K -$11.4K -6,633 -2%
Renaissance Technologies
8
Renaissance Technologies
New York
$315K -$337K -196,782 -45%
BCM
9
Bridgeway Capital Management
Texas
$243K +$68.5K +40,000 +27%
Ensign Peak Advisors
10
Ensign Peak Advisors
Utah
$197K +$192K +112,002 +282%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$103K – – –
Two Sigma Investments
12
Two Sigma Investments
New York
$76K -$174K -101,373 -63%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$66K -$170K -99,200 -66%
CM
14
Crestline Management
Texas
$45K -$760 -444 -1%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$39K -$50.6K -29,546 -49%
BC
16
BIT Capital
Germany
$39K -$34.3K -20,000 -40%
State Street
17
State Street
Massachusetts
$37K – – –
RJFSA
18
Raymond James Financial Services Advisors
Florida
$29K – – –
Millennium Management
19
Millennium Management
New York
$24K -$65.2K -38,051 -67%
Northern Trust
20
Northern Trust
Illinois
$24K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$21K -$210K -122,654 -89%
VF
22
Virtu Financial
New York
$19K +$3.48K +2,030 +16%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$17K -$260 -152 -1%
Goldman Sachs
24
Goldman Sachs
New York
$15K -$7.2K -4,201 -27%
Citigroup
25
Citigroup
New York
$15K +$19.9K +11,599 New
1
2

GRTX Hedge Fund Activity: Q2 2022 in Review

39 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q2 2022, worth a combined $13.7M — down 49% from $26.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GRTX and 2 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 5 added.

The largest buyer was Ensign Peak Advisors, adding an estimated $192K. The largest seller was Renaissance Technologies, cutting an estimated $337K.

  • 39 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q2 2022, down from 47 in Q1 2022.
  • Funds reported $13.7M of Galera Therapeutics, Inc. Common Stock stock for Q2 2022, down 49% quarter-over-quarter.
  • 2 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q2 2022 and 9 closed out, a net change of -7 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q2 2022 was Ensign Peak Advisors, an estimated $192K added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q2 2022 was Renaissance Technologies, an estimated $337K sold.

Based on aggregated 13F filings for Q2 2022.